Cargando…
Bifunctional Avidin with Covalently Modifiable Ligand Binding Site
The extensive use of avidin and streptavidin in life sciences originates from the extraordinary tight biotin-binding affinity of these tetrameric proteins. Numerous studies have been performed to modify the biotin-binding affinity of (strept)avidin to improve the existing applications. Even so, (str...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029397/ https://www.ncbi.nlm.nih.gov/pubmed/21305032 http://dx.doi.org/10.1371/journal.pone.0016576 |
_version_ | 1782197232045391872 |
---|---|
author | Leppiniemi, Jenni Määttä, Juha A. E. Hammaren, Henrik Soikkeli, Mikko Laitaoja, Mikko Jänis, Janne Kulomaa, Markku S. Hytönen, Vesa P. |
author_facet | Leppiniemi, Jenni Määttä, Juha A. E. Hammaren, Henrik Soikkeli, Mikko Laitaoja, Mikko Jänis, Janne Kulomaa, Markku S. Hytönen, Vesa P. |
author_sort | Leppiniemi, Jenni |
collection | PubMed |
description | The extensive use of avidin and streptavidin in life sciences originates from the extraordinary tight biotin-binding affinity of these tetrameric proteins. Numerous studies have been performed to modify the biotin-binding affinity of (strept)avidin to improve the existing applications. Even so, (strept)avidin greatly favours its natural ligand, biotin. Here we engineered the biotin-binding pocket of avidin with a single point mutation S16C and thus introduced a chemically active thiol group, which could be covalently coupled with thiol-reactive molecules. This approach was applied to the previously reported bivalent dual chain avidin by modifying one binding site while preserving the other one intact. Maleimide was then coupled to the modified binding site resulting in a decrease in biotin affinity. Furthermore, we showed that this thiol could be covalently coupled to other maleimide derivatives, for instance fluorescent labels, allowing intratetrameric FRET. The bifunctional avidins described here provide improved and novel tools for applications such as the biofunctionalization of surfaces. |
format | Text |
id | pubmed-3029397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30293972011-02-08 Bifunctional Avidin with Covalently Modifiable Ligand Binding Site Leppiniemi, Jenni Määttä, Juha A. E. Hammaren, Henrik Soikkeli, Mikko Laitaoja, Mikko Jänis, Janne Kulomaa, Markku S. Hytönen, Vesa P. PLoS One Research Article The extensive use of avidin and streptavidin in life sciences originates from the extraordinary tight biotin-binding affinity of these tetrameric proteins. Numerous studies have been performed to modify the biotin-binding affinity of (strept)avidin to improve the existing applications. Even so, (strept)avidin greatly favours its natural ligand, biotin. Here we engineered the biotin-binding pocket of avidin with a single point mutation S16C and thus introduced a chemically active thiol group, which could be covalently coupled with thiol-reactive molecules. This approach was applied to the previously reported bivalent dual chain avidin by modifying one binding site while preserving the other one intact. Maleimide was then coupled to the modified binding site resulting in a decrease in biotin affinity. Furthermore, we showed that this thiol could be covalently coupled to other maleimide derivatives, for instance fluorescent labels, allowing intratetrameric FRET. The bifunctional avidins described here provide improved and novel tools for applications such as the biofunctionalization of surfaces. Public Library of Science 2011-01-27 /pmc/articles/PMC3029397/ /pubmed/21305032 http://dx.doi.org/10.1371/journal.pone.0016576 Text en Leppiniemi et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Leppiniemi, Jenni Määttä, Juha A. E. Hammaren, Henrik Soikkeli, Mikko Laitaoja, Mikko Jänis, Janne Kulomaa, Markku S. Hytönen, Vesa P. Bifunctional Avidin with Covalently Modifiable Ligand Binding Site |
title | Bifunctional Avidin with Covalently Modifiable Ligand Binding Site |
title_full | Bifunctional Avidin with Covalently Modifiable Ligand Binding Site |
title_fullStr | Bifunctional Avidin with Covalently Modifiable Ligand Binding Site |
title_full_unstemmed | Bifunctional Avidin with Covalently Modifiable Ligand Binding Site |
title_short | Bifunctional Avidin with Covalently Modifiable Ligand Binding Site |
title_sort | bifunctional avidin with covalently modifiable ligand binding site |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029397/ https://www.ncbi.nlm.nih.gov/pubmed/21305032 http://dx.doi.org/10.1371/journal.pone.0016576 |
work_keys_str_mv | AT leppiniemijenni bifunctionalavidinwithcovalentlymodifiableligandbindingsite AT maattajuhaae bifunctionalavidinwithcovalentlymodifiableligandbindingsite AT hammarenhenrik bifunctionalavidinwithcovalentlymodifiableligandbindingsite AT soikkelimikko bifunctionalavidinwithcovalentlymodifiableligandbindingsite AT laitaojamikko bifunctionalavidinwithcovalentlymodifiableligandbindingsite AT janisjanne bifunctionalavidinwithcovalentlymodifiableligandbindingsite AT kulomaamarkkus bifunctionalavidinwithcovalentlymodifiableligandbindingsite AT hytonenvesap bifunctionalavidinwithcovalentlymodifiableligandbindingsite |